跳至主要内容
临床试验/CTRI/2014/07/004804
CTRI/2014/07/004804已完成2 期

A two arm randomized, open labeled, prospective, multi-centre, clinical study to evaluate efficacy and safety of Dabur Ratnaprash in health & immunity related parameters

Dabur India Ltd0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male and female subjects aged 18 to 60 years (both the ages inclusive)
  • Ready to provide written informed consent
  • No history of any known allergy with Chyawanprash like products or any of the ingredientts of the Ratnaprash
  • Willing to come for the follow up visits for evaluation

排除标准

  • Presence of clinically significant abnormal laboratory, ECG or X-ray findings during screening.
  • Patients with known uncontrolled diabetes mellitus (DM), hypertension (HT), symptomatic congestive heart failure (CHF), unstable angina pectoris, myocardial infarction (MI)
  • Patients participated in another clinical drug trial within 3 months before recruitment in this trial
  • Any other medical condition that in the Investigators opinion would preclude patient participation
  • Pregnant and breast feeding women and women of child bearing age refusing to use contraceptive measures
  • Immunologically compromised individuals

研究者

相似试验